JPH06240289A - Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester - Google Patents
Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl esterInfo
- Publication number
- JPH06240289A JPH06240289A JP19127492A JP19127492A JPH06240289A JP H06240289 A JPH06240289 A JP H06240289A JP 19127492 A JP19127492 A JP 19127492A JP 19127492 A JP19127492 A JP 19127492A JP H06240289 A JPH06240289 A JP H06240289A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl ester
- dha
- mixture
- acid
- sulfuric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はドコサヘキサエン酸(以
下、DHAと略称する)の製造に有用なDHAエチルエ
ステルを含有する脂肪酸エチルエステル混合物の製造方
法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a process for producing a fatty acid ethyl ester mixture containing DHA ethyl ester useful for producing docosahexaenoic acid (hereinafter abbreviated as DHA).
【0002】[0002]
【従来技術と発明が解決すべき課題】ドコサヘキサエン
酸(DHA)は、油脂、特にある種の魚の魚油、例えば
マグロやカツオの頭部の油、に多量に含有されているオ
メガー3・脂肪酸である。近年、DHAが様々な生理作
用に関与していることが明らかにされたことから医学分
野で注目を集めている。例えば、脳細胞の活性化による
血管性痴呆症やアルツハイマー症等の老人性痴呆症の改
善、眼細胞の活性化による視力の回復、さらには花粉
症、喘息等のアレルギー症状の改善など、様々な作用が
期待されている。ところで、DHAを医薬として、また
は研究に使用するためには、高純度のDHAが安定的に
供給される必要がある。原油を脱臭、脱酸、脱色処理す
ることからなる食用油の精製法で得られるトリグリセリ
ドのままの精製油は、DHAの含有率が約25%にすぎ
ず上記の目的には到底用い得ない。これは、DHAの含
量が高い魚油であっても、トリグリセリドに含まれる脂
肪酸3分子の内1または2分子がDHAであって、他は
エイコサペンタエン酸(EPA)、オレイン酸、パルミ
チン酸、ステアリン酸、リノール酸等の他の脂肪酸であ
ることに起因する。BACKGROUND OF THE INVENTION Docosahexaenoic acid (DHA) is an omega-3 fatty acid contained in large amounts in fats and oils, especially in fish oils of certain fish, such as tuna and bonito head oil. . In recent years, it has been clarified that DHA is involved in various physiological actions, and thus has attracted attention in the medical field. For example, improvement of senile dementia such as vascular dementia and Alzheimer's disease due to activation of brain cells, restoration of visual acuity due to activation of eye cells, and further improvement of allergic symptoms such as pollinosis and asthma. Expected to work. By the way, in order to use DHA as a medicine or for research, it is necessary to stably supply high-purity DHA. The refined oil as a triglyceride obtained by the refining method of edible oil, which comprises deodorizing, deoxidizing and decolorizing crude oil, has a DHA content of only about 25% and cannot be used for the above purpose. This is because even if fish oil has a high content of DHA, one or two of the three fatty acid molecules contained in triglyceride are DHA, and the others are eicosapentaenoic acid (EPA), oleic acid, palmitic acid, stearic acid. , Other fatty acids such as linoleic acid.
【0003】したがって、トリグリセリドである油脂か
ら高純度のDHAを得るためには、まず油脂を加水分解
して脂肪酸とグリセリンに分解し、次いで、加水分解混
合物から分子蒸留等によってDHAを分離、精製する。
この場合、脂肪酸の形では分離が困難であり、また工程
中に分解し易いために、エステル誘導体として分子量を
変え、低沸点で蒸発し易くすると共に、工程の途中での
酸化等による変化を防止している。したがって、原油
(主として魚油)からのDHAの分離精製は以下の工程
を含む。 1)DHAを含有する原油を酸で洗浄した後、アルカリ
加水分解して脂肪酸とグリセリンに分解する。 2)アルコールと硫酸の存在下で脂肪酸をエステルに変
換しエステル混合物を得る。 3)エステル混合物からDHAエステルを分離、精製
し、高純度のDHAエステルを得る。 上記の工程はアルカリ加水分解およびエステル化に手数
を要することから、より効率のよい、経済的な方法が望
まれていた。Therefore, in order to obtain high-purity DHA from triglyceride fats and oils, the fats and oils are first hydrolyzed into fatty acids and glycerin, and then DHA is separated and purified from the hydrolysis mixture by molecular distillation or the like. .
In this case, the fatty acid form is difficult to separate and easily decomposes during the process, so the molecular weight of the ester derivative is changed to facilitate evaporation at a low boiling point and prevent changes due to oxidation etc. during the process. is doing. Therefore, separation and purification of DHA from crude oil (mainly fish oil) includes the following steps. 1) Crude oil containing DHA is washed with an acid and then hydrolyzed with alkali to decompose into fatty acid and glycerin. 2) A fatty acid is converted into an ester in the presence of alcohol and sulfuric acid to obtain an ester mixture. 3) Separation and purification of DHA ester from the ester mixture to obtain highly pure DHA ester. Since the above steps require time and labor for alkali hydrolysis and esterification, a more efficient and economical method has been desired.
【0004】[0004]
【課題を解決するための手段】本発明者らは医薬として
有用なDHAを安価に得るために、その効率のよい精製
方法を提供することを目的として鋭意研究を重ねた結
果、ある条件下でDHAを含有する原油を処理すると、
1工程で脂肪酸エステル混合物に変換することが可能で
あることを見い出し、本発明を完成するに至った。即
ち、本発明は、DHAを含む原油1重量部に、0.8〜
1.2重量部のエチルアルコールと0.08〜0.11
重量部の硫酸とを混合し、8〜12時間加熱還流した
後、アルコールを留去し、残留物から硫酸を除去するこ
とからなるDHAエチルエステルを含有する脂肪酸エチ
ルエステル混合物の製造方法を提供するものである。本
発明の脂肪酸エチルエステル混合物は、高純度のDHA
エステルの製造に有用である。即ち、該混合物を常法通
り分子蒸留に付してDHAエチルエステルを分離、濃縮
し、例えば硝酸銀法で精製することにより純度95%以
上のDHAエチルエステルを得る。本発明方法に用いる
原油はDHAを多く含むものであれば特に限定されない
が、例えばマグロやカツオの頭部の油から得られる魚油
が適当である。原油は常法通り水と硫酸の混合物で洗浄
してタンパク質およびガム質を除去しておくことが好ま
しい。Means for Solving the Problems The present inventors have conducted diligent research to provide an efficient purification method for obtaining DHA, which is useful as a drug, at low cost, and as a result, under certain conditions. When processing crude oil containing DHA,
It has been found that it is possible to convert to a fatty acid ester mixture in one step, and the present invention has been completed. That is, the present invention provides 0.8 parts by weight of 1 part by weight of crude oil containing DHA.
1.2 parts by weight of ethyl alcohol and 0.08-0.11.
Provided is a method for producing a fatty acid ethyl ester mixture containing a DHA ethyl ester, which comprises mixing 1 part by weight of sulfuric acid, heating and refluxing for 8 to 12 hours, and then distilling off alcohol to remove sulfuric acid from the residue. It is a thing. The fatty acid ethyl ester mixture of the present invention is highly pure DHA.
It is useful for the production of esters. That is, the mixture is subjected to molecular distillation according to a conventional method to separate and concentrate DHA ethyl ester, and then purified by, for example, the silver nitrate method to obtain DHA ethyl ester having a purity of 95% or more. The crude oil used in the method of the present invention is not particularly limited as long as it contains a large amount of DHA. For example, fish oil obtained from the oil of the head of tuna or skipjack is suitable. The crude oil is preferably washed with a mixture of water and sulfuric acid in a conventional manner to remove proteins and gums.
【0005】アルコールは、脂肪酸とエステルを形成し
た時、分子蒸留によってDHAエステルを他の脂肪酸の
エステルから容易に分離することができることを条件と
して、任意に選択される。低級アルコールが好ましく、
最も好ましいのはエチルアルコールである。アルコール
の純度は95〜99%であることが好ましく、特に純度
99%であることが好ましい。また、硫酸も純度95〜
99%、特に純度99%のものを用いるのがよい。3成
分の配合比率は、原油1重量部に対して、例えばエチル
アルコールを0.8〜1.2重量部、好ましくは1〜
1.2重量部、より好ましくは1重量部、硫酸を0.0
8〜0.11重量部、好ましくは0.1〜0.11重量
部、より好ましくは0.1重量部とする。これらの混合
物を還流装置及び撹拌機を備えた反応釜に入れて加熱還
流する。エチルアルコールを用いた場合、還流時の温度
は約95℃である。反応時間は通常8〜12時間、好ま
しくは9〜10時間、最も好ましくは約10時間であ
る。しかしながら加熱時間は特に限定的でなく、これ以
上であってもよい。次いでアルコールを蒸留して除き、
残留する脂肪酸エチルエステル混合物から硫酸を除去す
る。硫酸は温水洗浄で容易に除去できる。温水の温度は
70〜95℃、好ましくは90〜95℃、より好ましく
は95℃である。本発明方法によれば、原油に含まれる
脂肪酸の約95%またはそれ以上がエステル化され、混
合物として得られる。原油、エチルアルコールおよび硫
酸が1:0.7:0.3の場合には、55%と低収率で
あったた。次いで本発明の脂肪酸エチルエステル混合物
を分子蒸留機にかけてDHAエチルエステルを濃縮し、
これを硝酸銀法で精製し、高純度のDHAエチルエステ
ルを得ることができる。以下に実施例を挙げ、本発明を
さらに詳しく説明する。Alcohols are arbitrarily selected, provided that when they form an ester with a fatty acid, the DHA ester can be easily separated from the ester of another fatty acid by molecular distillation. Lower alcohols are preferred,
Most preferred is ethyl alcohol. The purity of alcohol is preferably 95 to 99%, and particularly preferably 99%. Also, sulfuric acid has a purity of 95-
It is preferable to use 99%, particularly 99% pure. The mixing ratio of the three components is, for example, 0.8 to 1.2 parts by weight of ethyl alcohol, preferably 1 to 1 part by weight of crude oil.
1.2 parts by weight, more preferably 1 part by weight, sulfuric acid 0.0
The amount is 8 to 0.11 part by weight, preferably 0.1 to 0.11 part by weight, and more preferably 0.1 part by weight. These mixtures are heated and refluxed in a reaction kettle equipped with a reflux device and a stirrer. When using ethyl alcohol, the temperature at reflux is about 95 ° C. The reaction time is usually 8 to 12 hours, preferably 9 to 10 hours, most preferably about 10 hours. However, the heating time is not particularly limited and may be longer than that. Then the alcohol is distilled off,
The sulfuric acid is removed from the residual fatty acid ethyl ester mixture. Sulfuric acid can be easily removed by washing with warm water. The temperature of the warm water is 70 to 95 ° C, preferably 90 to 95 ° C, more preferably 95 ° C. According to the method of the present invention, about 95% or more of the fatty acids contained in crude oil are esterified and obtained as a mixture. When crude oil, ethyl alcohol, and sulfuric acid were 1: 0.7: 0.3, the yield was low at 55%. The fatty acid ethyl ester mixture of the present invention is then subjected to a molecular distillation machine to concentrate the DHA ethyl ester,
This can be purified by the silver nitrate method to obtain high-purity DHA ethyl ester. Hereinafter, the present invention will be described in more detail with reference to examples.
【0006】[0006]
【実施例】実施例1 硫酸および水による洗浄処理したDHAを含有する原油
(原油中の脂肪酸の比率;DHA:25%、EPA:6
%、オレイン酸:17%、パルミチン酸:15%、ステ
アリン酸:4%、リノール酸:2%)600kgを、エ
チルアルコール(純度99%)600kg、および硫酸
(純度99%)60kgと共に撹拌機および還流装置を
備えた反応釜に入れ、95℃で10時間加熱還流する。
次にエチルアルコールを蒸留して回収する。残留物を1
000kgの温水(95℃)で5回洗浄することによ
り、脂肪酸エチルエステル混合物570kgを得る。該
混合物は原油中の脂肪酸の95%を含む脂肪酸エチルエ
ステル混合物であった。 Example 1 Crude oil containing DHA washed with sulfuric acid and water (ratio of fatty acid in crude oil; DHA: 25%, EPA: 6
%, Oleic acid: 17%, palmitic acid: 15%, stearic acid: 4%, linoleic acid: 2%) 600 kg, 600 kg of ethyl alcohol (purity 99%) and 60 kg of sulfuric acid (purity 99%) together with a stirrer and It is put in a reaction kettle equipped with a reflux device and heated under reflux at 95 ° C. for 10 hours.
The ethyl alcohol is then distilled and recovered. 1 residue
570 kg of fatty acid ethyl ester mixture is obtained by washing 5 times with 000 kg of warm water (95 ° C.). The mixture was a fatty acid ethyl ester mixture containing 95% of the fatty acids in the crude oil.
【0007】参考例1 実施例1で得た脂肪酸エチルエステル混合物500kg
を分子蒸留機に入れ、真空度0.008mmHg、塔内
温度180℃で蒸留し、初留分と残留分を除き、主留分
を取ることにより、粗DHAエチルエステル濃縮物(3
7%)を得る。濃縮物100Lをヘキサン140Lに溶
解し、硝酸銀溶液153Lに撹拌しながら投入した後、
静置して分離させ、ヘキサン層を除去しDHAエチルエ
ステルを含有する硝酸銀溶液を得る。この硝酸銀溶液に
トルエン4160Lを加えて静置し、硝酸銀層を除去す
る。次いでトルエンを留去し残留物として純度95%以
上のDHAエチルエステル24Lを得る。 Reference Example 1 500 kg of the fatty acid ethyl ester mixture obtained in Example 1
Was placed in a molecular distillation machine and distilled at a vacuum degree of 0.008 mmHg and an internal temperature of 180 ° C. to remove the first fraction and the residual fraction, and to remove the main fraction to obtain a crude DHA ethyl ester concentrate (3
7%). Dissolve 100 L of the concentrate in 140 L of hexane and add to 153 L of silver nitrate solution with stirring,
The mixture is allowed to stand and separated, and the hexane layer is removed to obtain a silver nitrate solution containing DHA ethyl ester. To this silver nitrate solution, 4160 L of toluene was added and allowed to stand, and the silver nitrate layer was removed. Then, toluene is distilled off to obtain 24 L of DHA ethyl ester having a purity of 95% or more as a residue.
【0008】[0008]
【効果】本発明方法によれば、従来法に比較して効率よ
くDHAエチルエステルを含有する脂肪酸エチルエステ
ル混合物を得ることができる。この混合物から容易に純
度95%以上のDHAエチルエステルを得る。このDH
Aエチルエステルは重要な生理活性を有し、様々な疾
患、症状の治療に有用性が期待されており、本発明方法
はその開発並びに研究の推進に寄与し得るものである。According to the method of the present invention, a fatty acid ethyl ester mixture containing DHA ethyl ester can be obtained more efficiently than in the conventional method. From this mixture, DHA ethyl ester having a purity of 95% or more can be easily obtained. This DH
A-ethyl ester has an important physiological activity and is expected to be useful for treating various diseases and symptoms, and the method of the present invention can contribute to the development and promotion of research.
Claims (1)
に、0.8〜1.2重量部のエチルアルコールと0.0
8〜0.11重量部の硫酸とを混合し、8〜12時間加
熱還流した後、アルコールを留去し、残留物から硫酸を
除去することからなるドコサヘキサエン酸エチルエステ
ルを含有する脂肪酸エチルエステル混合物の製造方法。1. 0.8 to 1.2 parts by weight of ethyl alcohol and 0.0 to 1 part by weight of crude oil containing docosahexaenoic acid.
Fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester, which comprises mixing 8 to 0.11 parts by weight of sulfuric acid, heating and refluxing for 8 to 12 hours, distilling off alcohol, and removing sulfuric acid from the residue. Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19127492A JPH06240289A (en) | 1992-06-09 | 1992-06-09 | Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19127492A JPH06240289A (en) | 1992-06-09 | 1992-06-09 | Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06240289A true JPH06240289A (en) | 1994-08-30 |
Family
ID=16271828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19127492A Pending JPH06240289A (en) | 1992-06-09 | 1992-06-09 | Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06240289A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7550613B2 (en) | 2005-05-04 | 2009-06-23 | Pronova Biopharma Norge As | Compounds |
US8399516B2 (en) | 2006-11-01 | 2013-03-19 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) |
WO2014054435A1 (en) * | 2012-10-01 | 2014-04-10 | 日清ファルマ株式会社 | Method for producing composition containing higher unsaturated fatty acid alkyl ester |
CN103880672A (en) * | 2014-03-20 | 2014-06-25 | 江苏中邦制药有限公司 | High-purity DHA algae oil ethyl ester and preparation method for transferring high-purity DHA algae oil ethyl ester into glyceride |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57149400A (en) * | 1981-03-12 | 1982-09-14 | Kureha Chemical Ind Co Ltd | Manufacture of high purity long chain highly unsaturated fatty acid ester |
-
1992
- 1992-06-09 JP JP19127492A patent/JPH06240289A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57149400A (en) * | 1981-03-12 | 1982-09-14 | Kureha Chemical Ind Co Ltd | Manufacture of high purity long chain highly unsaturated fatty acid ester |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7550613B2 (en) | 2005-05-04 | 2009-06-23 | Pronova Biopharma Norge As | Compounds |
US8034842B2 (en) | 2005-05-04 | 2011-10-11 | Pronova Biopharma Norge As | Compounds |
US8618165B2 (en) | 2005-05-04 | 2013-12-31 | Pronova Biopharma Norge As | Compounds |
US8399516B2 (en) | 2006-11-01 | 2013-03-19 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) |
WO2014054435A1 (en) * | 2012-10-01 | 2014-04-10 | 日清ファルマ株式会社 | Method for producing composition containing higher unsaturated fatty acid alkyl ester |
US9365800B2 (en) | 2012-10-01 | 2016-06-14 | Nisshin Pharma Inc. | Method for producing composition containing highly unsaturated fatty acid alkyl ester |
JPWO2014054435A1 (en) * | 2012-10-01 | 2016-08-25 | 日清ファルマ株式会社 | Method for producing highly unsaturated fatty acid alkyl ester-containing composition |
CN103880672A (en) * | 2014-03-20 | 2014-06-25 | 江苏中邦制药有限公司 | High-purity DHA algae oil ethyl ester and preparation method for transferring high-purity DHA algae oil ethyl ester into glyceride |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0255824B1 (en) | A process for the production of refined fish oil concentrate | |
JP6889700B2 (en) | Very long chain polyunsaturated fatty acids derived from natural oils | |
US4004041A (en) | Production of liquid edible oil from palm oil or similar oils | |
JPS60133094A (en) | Manufacture of high purity eicosapentaenoic acid | |
JP2011527319A (en) | Extraction method of squalene, sterol and vitamin E contained in physically refined condensate and / or deodorized distillate of vegetable oil | |
JPH11236591A (en) | Preparation of highly pure eicosapentaenoic acid or its ester | |
JP5861968B2 (en) | Method for obtaining omega-3 concentrate | |
JPH0853692A (en) | Process for producing polyunsaturated fatty acid ester concentrate | |
JP2013151689A (en) | Method for producing fatty acid composition containing dha | |
JPH0225447A (en) | Production of highly unsaturated fatty acids | |
JPS63162796A (en) | Fractionation of fatty acid | |
JPS649977B2 (en) | ||
JP2600010B2 (en) | Countercurrent dry fractional crystallization | |
CN105779140A (en) | Preparation method of ethyl ester type fish oil with high EPA content | |
JPH07242895A (en) | Eicosapentaenoic acid of high purity and isolation and purification of lower alcohol ester thereof | |
JPH08100191A (en) | Purification of highly unsaturated fatty acid or ester thereof | |
EP0724557B1 (en) | A process for separating lipophilic compounds | |
CN1732251A (en) | Method for recovering phytosterol form by-product of vegetable oil refining | |
US3158541A (en) | Product for reduction of blood cholesterol concentration | |
JPH06240289A (en) | Production of fatty acid ethyl ester mixture containing docosahexaenoic acid ethyl ester | |
JP3340182B2 (en) | Method for producing triglyceride containing docosahexaenoic acid | |
JP6426192B2 (en) | Triterpene ester concentration | |
JP4393640B2 (en) | Production of plant sterols | |
US5700509A (en) | Method of fractionating an edible oil containing 2-palmitoyl-1,3-dioleylglycerol | |
JPH07110956B2 (en) | Process for producing eicosapentaenoic acid or its ester and docosahexaenoic acid or its ester |